Device Trial Radar · NCT01636648
Enable I Long-term Follow-up Study
Last checked: Nov 20, 2026Latest source record: Nov 21, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
42
Actual
Start
Aug 2012
Primary completion
Apr 2016
Study completion Apr 2016
Sponsor
- Lead sponsor
- Medtronic Cardiac Rhythm and Heart FailurePublic (MDT)
- Sponsor type
- Industry
- First posted
- Jul 10, 2012
Design
- Study type
- Observational
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This was a prospective, non-randomized, multi-center, non-interventional post-market study. The study was a post-market long-term follow-up study based on the same cohort of patients (148 patients) enrolled in a previous investigational study from March 2007 to December 2009 (ATS 3f Enable™ Aortic Bioprosthesis Model 6000, number S2005) involving 10 European sites. Patient follow-up took place on a yearly basis up to 10 years after the implant/enrollment. The primary objective of this study was to evaluate the safety and effectiveness of the Medtronic ATS Enable Aortic Bioprosthesis during long-term follow-up. As this was an observational study, safety and efficacy data were summarized and described. There was no statistically powered study hypothesis.
Conditions
- Aortic Valve Stenosis
- Aortic Valve Insufficiency
Interventions
Aortic Valve ReplacementDevice
Aortic Valve Replacement with Medtronic ATS 3f ENABLE® Aortic Bioprosthesis Model 6000
Primary outcomes
What the sponsor says the trial is designed to measure.
- Assess the Long-term safety of the Medtronic ATS Enable Aortic BioprosthesisTime frame: 10 Years Post-Procedure
- Assess the Long-term Clinical Effectiveness of the Medtronic ATS Enable Aortic Bioprosthesis: NYHA Functional ClassificationTime frame: 10 Years Post-Procedure
- Long-term Effectiveness of the Medtronic ATS Enable Aortic Bioprosthesis: Hemodynamic PerformanceTime frame: 10 Years Post-Procedure
Locations
6 sites in 3 countries. Site status is shown where the registry gives one.
Johann Wolfgang Goethe University
Frankfurt, Germany
University Medical Center Freiburg
Freiburg im Breisgau, Germany
University Medical Center Kiel
Kiel, Germany
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.